Market Outlook

By 2035, the U.S. Single-Use Medical Devices Market is expected to reach approximately USD 247.52 billion, growing at a CAGR of 9.10% during the forecast period 2026–2035. The market was valued at an estimated USD 103.60 billion in 2025, with historical analysis covering 2021 to 2024. Values in this report are expressed in USD billions.

The U.S. single-use medical devices industry represents one of the largest recurring-revenue pools within the national medical technology ecosystem. Unlike capital equipment markets that depend on multiyear replacement cycles, single-use devices are consumed continuously across inpatient admissions, surgical procedures, infusion therapy, diagnostic testing, emergency medicine, wound management, respiratory care, interventional procedures, outpatient treatment, and home-based healthcare. Every patient encounter involving vascular access, medication administration, blood collection, catheterization, sterile procedural preparation, wound treatment, or disposable patient monitoring creates recurring demand.

For the purposes of this market assessment, single-use medical devices are defined as regulated devices intended for one use or for use on a single patient during one procedure. The commercial scope includes syringes, needles, vascular-access products, administration sets, catheters, collection devices, procedure-specific disposables, surgical consumables, disposable wound-care products, respiratory and anesthesia disposables, selected infection-prevention devices, single-use sensors, and related sterile consumables. Durable capital equipment, pharmaceuticals, general-purpose nonmedical protective products, and reusable surgical instruments are excluded to prevent category inflation and double counting.

The market expanded from approximately USD 71.30 billion in 2021 to USD 95.00 billion in 2024, reflecting the normalization of elective procedures after the pandemic, elevated infection-prevention requirements, expansion of outpatient care, rising utilization of safety-engineered devices, and greater hospital emphasis on supply-chain resilience. Market value reached approximately USD 103.60 billion in 2025, supported by rising procedural volumes, increased utilization intensity per patient encounter, higher penetration of specialty disposable devices, inflation-adjusted contract pricing, and growing demand from home healthcare and ambulatory settings.

A defining feature of the market is that hospitals increasingly evaluate disposable devices through total clinical and operational economics rather than unit acquisition price alone. Products capable of reducing needlestick injuries, medication errors, contamination risk, catheter complications, procedure setup time, nursing workload, inventory complexity, or hospital-acquired infections can justify premium pricing even within highly cost-sensitive purchasing categories. This is shifting competition away from purely commodity manufacturing toward integrated solutions combining device safety, workflow performance, supply reliability, traceability, packaging efficiency, and clinical evidence.

The market is expected to remain structurally resilient through 2035 because disposable-device consumption is linked directly to healthcare utilization. The United States has approximately 6,100 hospitals, more than 907,000 staffed hospital beds, and over 35.6 million hospital admissions annually. Hospital care spending reached approximately USD 1.6 trillion in 2024. These figures illustrate the scale of the clinical infrastructure consuming high volumes of sterile, procedure-specific, and patient-specific disposable devices every day.

 

Introduction

According to the U.S. Single-Use Medical Devices Market Report, the market is positioned at the intersection of infection prevention, clinical workflow efficiency, healthcare utilization, regulatory compliance, and supply-chain security. A single hospital admission can involve dozens or hundreds of disposable products, ranging from basic syringes and collection tubes to high-value interventional catheters, specialty wound products, procedural kits, closed-system transfer devices, and disposable physiologic sensors.

The underlying demand environment is strengthened by U.S. demographic trends. The population aged 65 years and older reached approximately 61.2 million in 2024, representing a rapidly expanding group with disproportionately high hospitalization rates, chronic disease prevalence, procedural utilization, medication administration requirements, wound-care needs, and home-health consumption. Diabetes alone affects approximately 38.4 million Americans, creating recurring demand for injection, monitoring, wound-management, vascular-access, and diagnostic consumables.

Infection prevention remains another central structural driver. Healthcare-associated infections continue to represent a major clinical and economic challenge even after significant national improvement. A recent national prevalence assessment found that approximately one in 38 hospitalized U.S. patients had at least one healthcare-associated infection on a given day. Devices that reduce cross-contamination, support aseptic workflows, provide closed fluid pathways, eliminate reprocessing steps, or reduce staff handling therefore retain substantial strategic importance.

The economics of single-use devices differ materially across product categories. Commodity products such as conventional syringes, basic tubing, collection products, and certain general procedural consumables operate under aggressive group-purchasing and distributor negotiations. Higher-value products such as specialty vascular-access devices, safety-engineered needles, advanced wound-care disposables, electrophysiology catheters, thrombectomy catheters, minimally invasive surgical instruments, closed-system transfer devices, and disposable monitoring sensors have stronger opportunities for clinical differentiation and pricing.

Another important characteristic is the interaction between original single-use devices and the regulated reprocessing industry. Selected devices originally labeled for single use can be reprocessed when appropriate regulatory, cleaning, sterilization, functional-performance, labeling, and quality requirements are met. Reprocessing creates a meaningful procurement alternative for certain hospitals seeking to reduce waste and device expenditure. It does not eliminate original-device demand, but it increases the importance of lifecycle economics, device durability, materials selection, sustainability metrics, and contracting strategies.

From 2026 through 2035, the strongest companies will increasingly operate as workflow partners rather than commodity vendors. Health systems will favor suppliers able to combine reliable supply, clinically validated product performance, contracting flexibility, SKU rationalization, procedure-specific standardization, inventory visibility, domestic or diversified manufacturing, and measurable labor or safety benefits.

 

Key Market Drivers: What’s Fueling the U.S. Single-Use Medical Devices Market Boom?

The first major driver is the enormous recurring volume of patient encounters across the U.S. healthcare system. More than 35 million hospital admissions annually generate sustained consumption of syringes, needles, catheters, IV administration products, specimen-collection devices, wound-care products, sterile procedure components, respiratory consumables, and monitoring accessories. Unlike durable devices, these products generate recurring replacement demand after each patient or procedure.

A second driver is the continued prioritization of infection prevention. Single-use products reduce the need for cleaning and sterilization between patients and can simplify standardized aseptic workflows. This is particularly relevant for vascular access, urinary catheterization, respiratory therapy, procedural preparation, wound management, blood collection, and invasive interventions. Hospital quality teams increasingly evaluate device choices through infection outcomes, contamination pathways, nursing practices, and compliance with standardized care bundles.

A third driver is the migration of procedures from inpatient hospitals toward ambulatory surgery centers, hospital outpatient departments, physician offices, specialty clinics, and office-based intervention laboratories. Outpatient settings operate with different economics than large hospitals. They generally require standardized, compact, fast-turnaround products with predictable procedure-level cost. This creates favorable conditions for procedure packs, preassembled kits, single-use instruments, safety-engineered injection products, disposable catheters, and products that minimize reprocessing infrastructure.

The fourth driver is an expanding older population. Americans aged 65 years and above increasingly account for a major share of hospital procedures, chronic disease management, cardiovascular interventions, orthopedic surgery, wound treatment, infusion therapy, urinary catheterization, respiratory treatment, and home-based care. Growth in this demographic supports both procedure-intensive high-value disposable devices and high-volume recurring products used in chronic disease management.

A fifth driver is workforce economics. U.S. hospitals continue to face nursing, sterile-processing, laboratory, and procedural staffing constraints. Disposable products that arrive sterile, preassembled, prefilled, preconnected, safety-enabled, or procedure-ready can reduce setup steps and staff handling. Hospitals are increasingly willing to evaluate a higher device price when it decreases nursing time, prevents setup errors, simplifies training, reduces sterile-processing requirements, or improves operating-room turnover.

A sixth driver is supply-chain resilience. The pandemic and subsequent disruptions involving syringes, IV products, sterilization capacity, freight networks, raw materials, and manufacturing interruptions altered U.S. procurement behavior. Large health systems now evaluate supplier redundancy, geographic manufacturing footprint, days of inventory, raw-material exposure, business-continuity planning, and domestic capacity alongside price. This gives manufacturers with strong U.S. manufacturing and distribution infrastructure a strategic advantage.

The seventh driver is the growth of higher-value safety-engineered devices. Needlestick prevention, closed fluid pathways, needleless access, integrated catheter stabilization, prefilled flushing systems, antimicrobial technologies, and engineered sharps protection are shifting selected categories away from pure commodity competition. These technologies can produce a measurable clinical and occupational-safety benefit, supporting more defensible pricing.

Finally, the rapid development of home healthcare is widening the customer base. Diabetes supplies, infusion accessories, wound-care products, respiratory disposables, urinary products, ostomy-related devices, and monitoring consumables increasingly move through direct-to-patient and home-distribution channels. The winning commercial model in this segment requires not only manufacturing strength but also payer access, logistics, patient support, refill management, and digital ordering capabilities.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. single-use medical devices market is increasingly centered on eliminating unnecessary clinical steps. The value proposition is shifting from “disposable versus reusable” toward whether a device can make a patient encounter safer, faster, more standardized, and less labor intensive.

Safety-engineered injection systems are a major innovation area. Automatic needle shielding, retractable needles, passive activation mechanisms, needle-free connectors, and integrated sharps protection are being incorporated into products that historically competed primarily on price. These features are especially valuable in high-volume hospital departments, vaccination programs, emergency care, oncology, infusion centers, and other environments where occupational exposure risk is significant.

Vascular access is also becoming more technology intensive. Next-generation peripheral IV catheters, midline products, extension sets, securement technologies, blood-control catheters, needleless connectors, antimicrobial components, closed flushing systems, and integrated placement solutions are designed to reduce catheter failure and workflow variation. Because peripheral vascular access is among the most common invasive procedures performed in hospitals, even small improvements in first-stick success, dwell time, complication rates, or nursing efficiency can produce substantial enterprise-level value.

Procedure customization represents another innovation theme. Hospitals and ASCs increasingly use custom procedure trays and standardized kits that combine multiple sterile components into a single workflow-specific pack. The commercial value extends beyond the components themselves because standardized packs can reduce preparation time, simplify inventory management, decrease picking errors, and lower the number of individual packages opened during procedures.

Single-use electronic technologies are creating a premium category within the traditionally low-tech disposable market. Disposable ECG electrodes, pulse-oximetry sensors, temperature probes, wearable biosensors, pressure-monitoring components, and specialty diagnostic patches are expanding as connected monitoring becomes embedded in inpatient, ambulatory, and home-care workflows. Over time, printed electronics, flexible sensors, RFID-enabled products, and digitally traceable devices are expected to create new recurring revenue pools.

Materials innovation is equally important. Hospitals, regulators, clinicians, and manufacturers are paying closer attention to DEHP, PVC, latex exposure, sterilization chemistry, packaging waste, and total material consumption. Manufacturers are responding with alternative polymers, lighter packaging, reduced material intensity, non-DEHP fluid pathways, recyclable components where clinically feasible, and manufacturing processes designed to lower environmental impact without compromising sterility or performance.

Supply-chain innovation is also becoming a competitive technology in its own right. Manufacturers are increasing automated domestic production, introducing redundant manufacturing lines, improving lot-level traceability, strengthening distributor inventory visibility, and expanding safety stock. Reliability is now part of the product value proposition because a low-cost disposable device has little value if a hospital cannot obtain it consistently.

 

Segmentation Insights

The U.S. Single-Use Medical Devices Market is segmented on the basis of product category, application, end user, technology type, and region.

 

By Product Category

Infusion, Injection and Vascular Access Devices

Infusion, injection, and vascular-access products represent the largest recurring product pool and are estimated to account for approximately 26% of the U.S. market in 2025, equivalent to nearly USD 26.9 billion. The category includes syringes, hypodermic needles, safety needles, peripheral IV catheters, midlines, selected central-access consumables, extension sets, connectors, administration sets, flushing products, and associated access components.

Demand is exceptionally resilient because these devices are used across virtually every major hospital department as well as physician offices, outpatient centers, oncology clinics, emergency services, home infusion, and long-term care. Growth is moving toward safety-engineered injection systems, blood-control IV catheters, needleless connectors, prefilled flush syringes, closed-system transfer technologies, and integrated vascular-access solutions.

Surgical and Procedure-Specific Disposable Devices

Surgical and procedural disposables account for approximately 22% of 2025 market value. The category spans disposable surgical instruments, minimally invasive procedural accessories, trocars, stapling components, suction products, drainage devices, procedural drapes, sterile packs, specialty catheters, guide accessories, electrosurgical consumables, and intervention-specific disposable systems.

The strongest value growth is occurring in minimally invasive procedures where sophisticated disposable instruments are paired with reusable capital platforms. Hospitals increasingly evaluate these products on procedure time, complication reduction, physician preference, ease of setup, and ability to shift procedures into outpatient environments.

Diagnostic and Specimen-Collection Devices

Diagnostic and specimen-collection products represent approximately 15% of the market. This includes blood-collection tubes, lancets, swabs, specimen containers, collection needles, disposable diagnostic cartridges, sample-transfer devices, point-of-care testing consumables, and selected single-use diagnostic accessories.

Demand is supported by the enormous U.S. laboratory testing infrastructure, chronic disease monitoring, preventive screening, hospital diagnostics, infectious disease surveillance, and expansion of decentralized point-of-care testing. Automation compatibility, specimen integrity, labeling, traceability, and reduced contamination risk are increasingly important purchasing criteria.

Wound Care, Ostomy and Drainage Products

Single-use wound and drainage products account for approximately 12% of the 2025 market. This segment includes dressings, advanced wound-care consumables, negative-pressure wound therapy disposables, wound-contact layers, drainage products, ostomy accessories, skin-protection products, and related patient-specific devices.

Growth is supported by diabetes, obesity, vascular disease, surgical wounds, pressure injuries, aging demographics, and greater treatment outside acute-care hospitals. Advanced dressings and wound-management consumables capable of reducing dressing-change frequency or improving exudate management can support premium pricing despite strong reimbursement sensitivity.

Infection-Prevention and Sterile Barrier Devices

Infection-prevention devices represent approximately 15% of market value. This category includes selected regulated masks and protective devices, sterile drapes, sterile barriers, procedure covers, isolation-related devices, closed-system products, protective sheaths, and other disposable products specifically used within clinical infection-control workflows.

The segment remains strategically important because healthcare-associated infections carry substantial quality, reimbursement, and patient-safety consequences. Procurement is increasingly linked to evidence that devices can reduce contamination opportunities, improve protocol adherence, or simplify aseptic practices.

Respiratory, Anesthesia and Monitoring Disposables

Respiratory, anesthesia, and monitoring consumables account for approximately 10% of the market and include breathing circuits, masks, cannulas, airway-management consumables, nebulizer accessories, filters, suction components, disposable sensors, electrodes, cuffs, probes, and other patient-contact accessories.

Growth is being supported by hospital respiratory care, procedural sedation, surgical volumes, emergency treatment, sleep and home respiratory care, and increased use of patient monitoring outside intensive-care environments. Disposable sensor technologies should expand faster than conventional respiratory accessories through 2035.

 

By Application

Medication Delivery and Infusion Therapy

Medication delivery and infusion therapy represent the largest application segment. Acute-care hospitals consume extremely high volumes of syringes, needles, IV catheters, connectors, tubing, flushing products, and medication-transfer devices. Oncology, biologic therapy, specialty pharmacy, ambulatory infusion, and home infusion are expanding the addressable market beyond inpatient settings.

Closed-system designs, prefilled devices, passive safety mechanisms, reduced-component workflows, and standardized connectivity will drive value growth faster than traditional commodity products.

Surgery and Interventional Procedures

Surgery and intervention form the highest-value application pool per procedure. Disposable devices are used throughout gastrointestinal, cardiovascular, orthopedic, urologic, gynecologic, ophthalmic, vascular, neurovascular, and general surgical workflows.

The growing sophistication of disposable procedural products creates attractive economics for manufacturers. Specialty catheters, thrombectomy devices, minimally invasive surgical accessories, ablation disposables, energy-delivery components, procedure packs, and advanced access technologies can command substantially higher average selling prices than general medical consumables.

Diagnostics and Specimen Management

Diagnostic applications include collection, handling, transport, processing, and point-of-care testing. High U.S. testing volumes create recurring consumption independent of capital-equipment replacement cycles.

Growth opportunities are increasingly concentrated in integrated collection devices, closed specimen-transfer products, automated-laboratory compatibility, molecular-diagnostic consumables, and point-of-care formats that reduce sample preparation requirements.

Wound and Chronic Disease Management

Wound care, diabetes management, ostomy care, urinary management, and other chronic applications generate recurring patient-specific demand over extended periods. This creates an attractive combination of repeat consumption and an expanding home-care channel.

The 38.4 million Americans estimated to have diabetes represent a particularly important underlying population because diabetes increases demand across injection, monitoring, wound, vascular, and renal-care product categories.

Infection Prevention, Respiratory and Critical Care

Critical-care and infection-prevention applications require large volumes of respiratory consumables, airway products, suction products, sterile barriers, catheters, tubing, protective devices, and monitoring accessories. Although utilization can fluctuate with hospitalization patterns, the category remains essential to acute-care operations.

Hospitals are likely to standardize more of these products through enterprise contracting while reserving premium spending for devices that demonstrate measurable safety or workflow advantages.

 

By End User

Hospitals and Integrated Health Systems

Hospitals and integrated health systems represent the dominant end-user category and account for an estimated 51% of U.S. market revenue in 2025. The scale is supported by more than 6,100 hospitals, over 907,000 staffed beds, and approximately 35.7 million annual admissions.

Large systems increasingly negotiate enterprise agreements through value-analysis committees, group purchasing organizations, and centralized supply-chain teams. Vendor selection can involve clinical quality, total procedure cost, supply assurance, SKU rationalization, standardization, sustainability, contracting flexibility, and clinician preference.

Ambulatory Surgery Centers and Outpatient Facilities

ASCs and hospital outpatient departments are expected to be among the fastest-growing end-user channels through 2035. Procedure migration creates demand for products that are easy to inventory, fast to deploy, standardized, and optimized around a predictable per-case cost.

Procedure packs and disposable instruments are especially attractive because many ASCs have less extensive sterile-processing infrastructure than major hospitals. Vendors able to simplify setup and reduce labor intensity can gain meaningful differentiation.

Physician Offices, Diagnostic Laboratories and Specialty Clinics

This segment generates demand for specimen-collection products, injection devices, diagnostic consumables, wound-care products, minor-procedure devices, infusion products, and point-of-care testing accessories.

Purchasing is more fragmented than in large hospital systems, giving distributors and broad-line suppliers substantial commercial influence. Convenient ordering, case-size flexibility, product availability, and price transparency are especially important.

Home Healthcare and Long-Term Care

Home healthcare, direct-to-patient supply, skilled nursing, and long-term care represent increasingly important channels. Diabetes products, infusion consumables, wound-care devices, ostomy products, urinary management, respiratory accessories, and selected monitoring devices generate recurring demand.

This channel will grow as payers and health systems attempt to manage appropriate patients outside high-cost hospital environments. Manufacturers with direct-to-patient logistics and reimbursement capabilities can capture a larger proportion of the value chain.

Emergency Medical Services and Other Care Settings

Emergency medical services, urgent care, public health programs, federal healthcare facilities, military medicine, dialysis centers, blood centers, and other specialized care environments contribute an important additional demand pool.

Purchasing priorities are frequently centered on portability, ease of training, storage stability, rapid deployment, supply availability, and standardization.

 

By Technology Type

Conventional Sterile Single-Use Devices

Conventional sterile disposable devices remain the largest technology category, representing nearly half of market revenue. These products include established syringes, tubing, collection products, basic catheters, procedure components, wound products, and respiratory accessories.

The category offers dependable volume but generally lower pricing power. Manufacturing scale, automation, distributor relationships, quality consistency, and supply reliability determine competitive performance.

Safety-Engineered Devices

Safety-engineered single-use devices represent one of the largest premium opportunities. Retractable needles, passive safety syringes, shielded sharps, needle-free connectors, blood-control catheters, protected collection devices, and similar technologies are designed to reduce occupational and patient risk.

This segment should expand faster than conventional disposables as health systems quantify staff injury, exposure, and downstream treatment costs.

Closed-System, Prefilled and Procedure-Ready Devices

Closed-system and procedure-ready products are gaining adoption because they reduce preparation steps and opportunities for contamination. Prefilled flush syringes, closed drug-transfer systems, preconnected fluid pathways, sterile procedure kits, and integrated administration devices can reduce nursing workload and variation.

This technology category is highly aligned with U.S. hospital efforts to improve workforce productivity.

Advanced Single-Use Interventional Devices

This segment includes technologically sophisticated disposable catheters, thrombectomy devices, ablation components, minimally invasive surgical instruments, specialty guide systems, and other high-value procedural devices.

Although unit volumes are smaller than commodity disposables, average selling prices are substantially higher. Growth is driven by minimally invasive care, complex intervention, outpatient migration, and procedure-specific innovation.

Disposable Sensors and Digitally Enabled Devices

Disposable sensors are expected to be among the fastest-growing technology categories through 2035. Single-patient ECG components, pulse-oximetry sensors, wearable monitoring patches, pressure-sensing disposables, temperature products, and digitally enabled diagnostic devices extend recurring-device economics into connected care.

As monitoring moves from ICUs to general wards, ambulatory environments, and homes, disposable sensor consumption is expected to increase significantly.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Single-Use Medical Devices Market is geographically divided into the South, Northeast, West, and Midwest. Regional performance varies according to population, hospital utilization, procedure volumes, age distribution, chronic disease prevalence, outpatient migration, hospital-system concentration, manufacturing presence, and purchasing behavior.

The South represents the largest regional market, estimated at approximately USD 40.00 billion in 2025, while the West is expected to record the fastest percentage growth through 2035. The Northeast remains particularly attractive for premium and innovation-driven products, whereas the Midwest provides substantial recurring volume and an important domestic medtech manufacturing base.

South

The South accounts for approximately 38.6% of the U.S. market in 2025, making it the largest regional opportunity. Under this report’s geographic framework, the region includes Texas, Florida, Georgia, North Carolina, Virginia, Tennessee, Maryland, South Carolina, Alabama, Kentucky, Louisiana, Oklahoma, Arkansas, Mississippi, West Virginia, Delaware, and the District of Columbia.

Texas is the region’s most important state market. Its population scale, major metropolitan healthcare ecosystems in Houston, Dallas-Fort Worth, Austin, and San Antonio, extensive hospital infrastructure, rapid suburban growth, and high chronic disease burden generate substantial consumption of vascular access, injection, surgical, diagnostic, wound, and interventional disposables. Texas also supports major distribution and manufacturing operations, making it strategically important for both sales and supply-chain design.

Florida is another exceptionally strong market. The state’s large older-adult population supports high utilization of cardiovascular procedures, orthopedic interventions, wound treatment, infusion therapy, urinary products, respiratory care, and home-health devices. Florida’s expanding ASC sector is particularly favorable for procedure kits and specialty single-use surgical devices.

North Carolina combines a fast-growing population with important academic medical centers and a substantial life-sciences manufacturing footprint. The state is strategically significant for pharmaceutical and medical supply chains, although the 2024 hurricane-related disruption affecting major healthcare manufacturing infrastructure demonstrated the need for geographic redundancy.

Georgia and Tennessee function as major regional healthcare and distribution centers. Atlanta and Nashville contain extensive hospital systems, healthcare companies, logistics infrastructure, and specialist networks that influence purchasing throughout the Southeast.

Virginia and Maryland benefit from dense health-system networks, large suburban populations, advanced academic centers, federal healthcare activity, and strong procedure volumes. South Carolina is experiencing population and retirement growth that is increasing utilization of hospital, outpatient, wound, and chronic-care devices.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, and West Virginia present a different demand profile. These states have substantial chronic disease burdens and significant rural populations. Demand is strong for fundamental hospital consumables, diabetes-related products, wound care, vascular access, respiratory devices, and home-care supplies, although adoption of high-value specialty devices is concentrated in metropolitan referral centers.

Delaware and the District of Columbia are smaller by population but remain relevant because of concentrated hospital utilization, sophisticated referral pathways, and proximity to large Mid-Atlantic health systems.

The South is forecast to exceed USD 97 billion by 2035, supported by population migration, expansion of outpatient infrastructure, aging demographics, hospital-system investment, and rising chronic disease treatment intensity.

West

The West represented approximately USD 23.00 billion in 2025 and is forecast to be the fastest-growing region through 2035. The region includes California, Washington, Arizona, Colorado, Oregon, Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is the dominant Western market and one of the largest individual state opportunities nationally. Its size is reinforced by a population approaching 40 million, sophisticated academic health systems, major integrated delivery networks, extensive ambulatory care infrastructure, and rapid adoption of advanced clinical technology. California is especially important for high-value single-use interventional devices, disposable sensors, minimally invasive surgery products, advanced wound care, and environmentally differentiated medical consumables.

California is also strategically important for sustainability-driven procurement. Large health systems increasingly scrutinize packaging, plastic consumption, chemicals of concern, product lifecycle impact, and supplier climate strategies. Manufacturers developing PVC alternatives, non-DEHP fluid pathways, material-light packaging, and lower-waste product formats are likely to encounter some of their earliest large-scale U.S. adoption in California.

Arizona and Nevada are among the strongest demographic growth markets. Both states benefit from population migration and increasing older-adult populations, supporting hospital admissions, orthopedic procedures, cardiovascular treatment, diabetes management, wound care, and home healthcare.

Washington and Oregon have sophisticated integrated health systems that frequently evaluate devices based on standardized clinical pathways, supply-chain performance, sustainability, and total cost of care. Both markets are attractive for connected monitoring, advanced disposable sensors, and clinical workflow technologies.

Colorado and Utah combine relatively young populations with rapidly expanding healthcare infrastructure and high rates of technology adoption. Denver, Salt Lake City, and surrounding markets have become increasingly important for specialty surgery, ambulatory care, and integrated delivery networks.

New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller markets but present specific distribution and logistics challenges. Reliable inventory, shipping continuity, product shelf life, and regional stocking can be more important than marginal price differences in geographically dispersed areas.

The West is expected to approach USD 59 billion by 2035, with growth led by California, Arizona, Nevada, Washington, Colorado, and Utah.

Northeast

The Northeast represented approximately USD 24.50 billion in 2025. The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Maine, New Hampshire, Vermont, and Rhode Island.

New York is the largest state market in the region. Its combination of major academic medical centers, dense urban hospitals, extensive outpatient networks, high procedural complexity, and large Medicaid and Medicare populations creates substantial demand across virtually every disposable-device category.

New York procurement can be highly consolidated through major health systems. Manufacturers therefore need sophisticated contracting strategies, clinical evidence, reliable distributor relationships, and the ability to meet systemwide standardization requirements.

Pennsylvania combines major metropolitan markets in Philadelphia and Pittsburgh with extensive community hospital networks. The state is a major consumer of surgical disposables, vascular-access products, diagnostic devices, wound-care products, and chronic-care supplies.

New Jersey benefits from high population density, strong commercial insurance penetration, pharmaceutical and medtech industry concentration, and close integration with New York and Philadelphia healthcare markets. The state is important both commercially and operationally for manufacturers.

Massachusetts remains disproportionately influential relative to population size because of its concentration of academic hospitals, biotechnology companies, clinical research programs, and early-adopting specialist physicians. Premium single-use devices frequently establish clinical credibility in Boston-based institutions before wider national diffusion.

Connecticut supports significant acute-care and outpatient demand and has important medical-device manufacturing activity. Rhode Island, New Hampshire, Maine, and Vermont are smaller markets but have aging populations that sustain demand for hospital, wound, respiratory, home-care, and chronic-disease consumables.

The Northeast is forecast to reach approximately USD 55–56 billion by 2035. Its percentage growth will trail the West and South because of slower population growth, but revenue per patient encounter should remain comparatively high because of procedural complexity and premium technology utilization.

Midwest

The Midwest represented approximately USD 16.10 billion in 2025. The region includes Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, Missouri, Iowa, Kansas, Nebraska, North Dakota, and South Dakota.

Illinois is the region’s largest commercial market, led by Chicago’s academic medical centers, major integrated health systems, community hospitals, laboratories, and outpatient networks. Large purchasing organizations can exert substantial price pressure, making economic differentiation and supply reliability particularly important.

Ohio is a significant market because of major hospital systems and high procedural capacity in Cleveland, Columbus, Cincinnati, and other metropolitan areas. The state generates substantial demand for vascular-access products, surgery disposables, wound-care devices, respiratory consumables, and advanced interventional products.

Michigan similarly provides a large acute-care and chronic-disease treatment base. Diabetes, cardiovascular disease, aging communities, and extensive health-system infrastructure support recurring demand.

Minnesota is strategically important beyond its population because it remains one of the most important U.S. medical technology clusters. The state’s clinical, engineering, manufacturing, and corporate capabilities make it influential in product development and commercialization.

Wisconsin, Indiana, and Missouri provide sizable health-system and outpatient markets. Iowa, Kansas, Nebraska, North Dakota, and South Dakota generate smaller absolute revenue but are important for distributor-driven sales, rural healthcare, regional referral networks, diabetes management, wound care, and home-use products.

Nebraska has become more strategically visible within the domestic medical-device manufacturing landscape because of investment in syringe and injection-device production. Such investments reinforce the Midwest’s role not merely as a demand region but as part of the U.S. supply-security strategy for high-volume disposable devices.

The Midwest is projected to exceed USD 35 billion by 2035. Growth will be less aggressive than in the South and West, but predictable procedure volumes and strong medical manufacturing infrastructure make the region commercially durable.

 

Key Market Players

The U.S. Single-Use Medical Devices competitive landscape is highly fragmented at the product level but considerably more concentrated in major enterprise accounts. Large suppliers benefit from broad portfolios, nationwide distribution, group-purchasing relationships, manufacturing scale, and the ability to bundle numerous disposable categories into system-level agreements.

At the same time, specialized manufacturers can capture premium positions in vascular access, interventional therapy, wound care, safety devices, sensors, and procedure-specific disposables when they demonstrate a clinically meaningful advantage.

Some of the key players operating across the U.S. Single-Use Medical Devices industry include:

Becton, Dickinson and Company (BD)
Cardinal Health
Medline Industries
Baxter International
B. Braun Medical
Johnson & Johnson MedTech
Stryker
Boston Scientific Corporation
Abbott
Teleflex Incorporated
ICU Medical
Terumo Medical Corporation
Merit Medical Systems
Cook Medical
AngioDynamics
Smith+Nephew
Mölnlycke Health Care
Convatec Group
Coloplast
Solventum
Integra LifeSciences
Nipro Medical Corporation
Fresenius Kabi
Owens & Minor
Masimo

BD, Cardinal Health, Medline, Baxter, and B. Braun hold particularly strong positions across high-volume hospital consumables, vascular access, infusion, injection, laboratory products, procedure supplies, and distribution. Their competitive advantage is based on manufacturing scale, extensive portfolios, contracting relationships, supply-chain infrastructure, and high customer switching costs.

Johnson & Johnson MedTech, Stryker, Boston Scientific, Abbott, Teleflex, Terumo, Merit Medical, Cook Medical, and AngioDynamics compete more heavily in specialty procedural and interventional categories, where disposable-device economics depend on physician preference, procedure outcomes, technology differentiation, and training.

Smith+Nephew, Mölnlycke, Convatec, Coloplast, Integra LifeSciences, and Solventum hold important positions in wound management, skin care, infection prevention, surgical consumables, and related recurring-use categories.

Competitive share through 2035 will increasingly be determined by five capabilities: clinical differentiation, guaranteed supply, manufacturing quality, health-system contracting, and portfolio breadth. Sustainability and domestic manufacturing will increasingly influence contract awards but are unlikely to replace fundamental requirements around clinical performance and price.

 

Recent Developments

Recent developments demonstrate that U.S. single-use medical device strategy is becoming inseparable from supply-chain resilience. In 2025, BD announced additional U.S. manufacturing capacity for critical products including syringes, needles, and IV catheters. New production lines were expected to increase domestic capacity for safety-engineered injection devices by more than 40% and conventional syringes by more than 50%, adding hundreds of millions of units annually.

BD subsequently announced an investment exceeding USD 35 million in Nebraska to expand production of prefilled flush syringes. The investment was designed to add hundreds of millions of units of annual capacity and formed part of a broader multiyear commitment to U.S. medical-device manufacturing. These investments demonstrate that high-volume disposables are increasingly viewed as critical healthcare infrastructure rather than low-strategic-value commodities.

Supply disruption following severe weather in 2024 also reinforced the vulnerability of concentrated medical-product manufacturing. Manufacturers and federal agencies responded by increasing output, relocating inventory, expanding production of tubing and administration devices, and implementing conservation measures. This event accelerated health-system focus on dual sourcing, regional inventory, emergency allocation planning, and supply assurance.

B. Braun subsequently strengthened its supply-resilience positioning by expanding inventory programs across its U.S. portfolio. The company announced a supply-assurance model targeting 45 days of inventory at selected distributor warehouses compared with a typical 24–28 days. For hospitals, greater inventory assurance can materially influence vendor preference in categories where product shortages disrupt routine care.

Regulation is also changing. The FDA’s Quality Management System Regulation became effective February 2, 2026, incorporating ISO 13485:2016 into the U.S. medical-device quality framework. For disposable-device manufacturers operating enormous production volumes, supplier control, risk management, process validation, complaint handling, traceability, and manufacturing consistency will remain critical areas of regulatory and procurement scrutiny.

Portfolio consolidation is expanding in specialty disposables. Stryker completed its acquisition of Inari Medical in February 2025, strengthening its position in peripheral vascular intervention and thrombectomy. Transactions of this type show why high-value disposable interventional products remain strategically attractive to major medtech companies: they combine strong procedure growth with recurring per-case revenue.

Distribution channels are also evolving toward the home. Cardinal Health expanded its direct-to-patient presence through its 2025 acquisition of Advanced Diabetes Supply Group, which serves approximately 500,000 patients annually. The strategic implication extends beyond diabetes: distributors increasingly want direct access to patients consuming recurring medical supplies outside traditional hospitals.

 

Conclusion

The U.S. Single-Use Medical Devices Market Size & Share is projected to increase from approximately USD 103.60 billion in 2025 to USD 247.52 billion by 2035, reflecting a CAGR of 9.10% during 2026–2035.

The market’s resilience is supported by recurring device consumption across more than 35 million annual hospital admissions, continued expansion of outpatient procedures, an aging population exceeding 61 million people aged 65 and above, significant chronic disease prevalence, and healthcare-system emphasis on infection prevention and staff productivity.

The strongest growth opportunities will not necessarily be found in the highest-volume commodity categories. Disproportionate value creation is expected in safety-engineered injection systems, integrated vascular access, procedure-ready kits, specialty interventional catheters, advanced wound products, closed-system fluid management, single-use sensors, and products that reduce clinical labor.

Hospitals will continue to exert pricing pressure on basic disposables, making manufacturing efficiency and scale essential. However, procurement committees are increasingly willing to evaluate total cost rather than unit price when evidence demonstrates reduced needlestick injuries, fewer complications, improved procedure turnover, lower labor requirements, reduced contamination exposure, or improved supply availability.

Supply-chain resilience has permanently changed purchasing behavior. Domestic production capacity, manufacturing redundancy, supplier transparency, distributor inventory, geographic diversification, and emergency allocation capabilities are becoming important determinants of long-term contracting. Manufacturers that depend excessively on concentrated production or fragile raw-material supply chains will face growing scrutiny.

Regional opportunity will remain led by the South, driven by Texas, Florida, North Carolina, Georgia, Tennessee, and other expanding markets. The West should achieve the fastest percentage growth, supported by California’s technology adoption and sustainability priorities alongside rapid population growth in Arizona, Nevada, Colorado, and Utah. The Northeast will remain a premium clinical innovation market, while the Midwest will retain strategic importance for both consumption and domestic manufacturing.

For manufacturers, distributors, investors, healthcare providers, and market-entry teams assessing the U.S. single-use medical devices industry, the most important strategic question is not whether disposable-device utilization will continue to grow. The more consequential question is which categories can escape commodity economics by solving measurable clinical, labor, safety, sustainability, and supply-chain problems.

Companies capable of combining reliable manufacturing, clinically differentiated products, evidence-based value propositions, health-system contracting expertise, regulatory execution, and resilient distribution will be best positioned to capture the next decade of growth in the U.S. Single-Use Medical Devices Market.

 

TABLE OF CONTENT

1. U.S. Single-Use Medical Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.2.1. Devices Included in the Market Scope
1.2.2. Market Exclusions and Boundary Definition
1.2.3. Original Single-Use Devices vs. Reprocessed Single-Use Devices
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Bottom-Up Market Sizing Approach
1.3.6. Top-Down Market Validation
1.3.7. Volume, ASP and Procedure-Based Modeling
1.3.8. Analytical Frameworks & Forecasting Models
1.3.9. Data Triangulation, Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Single-Use Medical Device Manufacturers
1.6.2. Raw Material and Medical-Grade Polymer Suppliers
1.6.3. Sterilization and Contract Manufacturing Providers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Ambulatory Surgery Centers and Outpatient Facilities
1.6.6. Physician Offices, Diagnostic Laboratories and Specialty Clinics
1.6.7. Home Healthcare and Long-Term Care Providers
1.6.8. Group Purchasing Organizations and Medical Distributors
1.6.9. Payers, FDA, CMS and Clinical Decision-Makers
1.6.10. Third-Party Single-Use Device Reprocessors

What this section provides: This section defines the U.S. single-use medical devices market boundary, product inclusion criteria, research methodology, analytical assumptions, value-chain structure, and stakeholder ecosystem so clients understand precisely how market estimates and forecasts are developed.

2. U.S. Single-Use Medical Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size, 2021–2035 (US$ Billion)
2.8. Market CAGR Analysis, 2026–2035 (%)
2.9. Leading Product Category, 2025
2.10. Fastest-Growing Product Category, 2026–2035
2.11. Leading Application Segment, 2025
2.12. Fastest-Growing Technology Segment, 2026–2035
2.13. Leading End-User Segment, 2025
2.14. Regional Leadership Analysis, 2025
2.15. High-Growth Opportunity Areas
2.16. Key Strategic Takeaways for Market Participants

What this section provides: This section gives senior decision-makers a concise view of market size, CAGR, historical performance, segment leadership, regional positioning, major demand pockets, competitive intensity, and the most attractive commercial opportunities through 2035.

3. U.S. Single-Use Medical Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. High Recurring Consumption Across U.S. Healthcare Facilities
3.1.2. Growing Hospital Emphasis on Infection Prevention and Aseptic Workflow
3.1.3. Expansion of Ambulatory Surgery and Outpatient Procedures
3.1.4. Rising U.S. Geriatric Population and Chronic Disease Burden
3.1.5. Growing Adoption of Safety-Engineered Medical Devices
3.1.6. Increasing Demand for Procedure-Ready and Prefilled Devices
3.1.7. Clinical Workforce Shortages and Workflow Efficiency Requirements
3.1.8. Expansion of Home Healthcare and Direct-to-Patient Medical Supply Models
3.1.9. Increasing Procedural Volumes in Minimally Invasive Care
3.1.10. Strategic Focus on U.S. Medical Supply-Chain Resilience

3.2. Restraints and Their Impact Analysis
3.2.1. Intense Pricing Pressure in Commodity Disposable Categories
3.2.2. GPO and Integrated Delivery Network Purchasing Power
3.2.3. Environmental Concerns Associated with Medical Plastic Waste
3.2.4. Raw Material and Sterilization Cost Volatility
3.2.5. Product Recalls and Quality-Control Risk
3.2.6. Competition from Regulated Single-Use Device Reprocessing
3.2.7. Supply Concentration and Manufacturing Disruption Risk

3.3. Opportunities and Their Impact Analysis
3.3.1. Safety-Engineered Injection and Sharps Protection Devices
3.3.2. Integrated and Closed Vascular Access Systems
3.3.3. Custom Procedure Trays and Procedure-Ready Kits
3.3.4. Advanced Single-Use Interventional Catheters
3.3.5. Disposable Digital Sensors and Connected Monitoring Devices
3.3.6. Sustainable and Lower-Waste Single-Use Medical Devices
3.3.7. Domestic Manufacturing and Supply Localization
3.3.8. Home-Based Infusion, Wound Care and Chronic Disease Management
3.3.9. ASC-Specific Disposable Device Portfolios

3.4. Challenges and Their Impact Analysis
3.4.1. Balancing Cost Reduction with Product Innovation
3.4.2. Sterilization Capacity Constraints
3.4.3. Medical-Grade Polymer Supply Dependence
3.4.4. Complex Health-System Product Standardization
3.4.5. SKU Proliferation and Inventory Complexity
3.4.6. Sustainability vs. Infection-Control Trade-Offs

3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Cost-Per-Procedure Analysis
3.8. Hospital Disposable Device Procurement Behavior Analysis
3.9. Single-Use vs. Reusable Device Economic Analysis
3.10. Original Single-Use vs. Reprocessed Device Economics
3.11. Supply Shortage Risk and Business Continuity Analysis

What this section provides: This section evaluates the clinical, economic, demographic, infection-control, operational, environmental, and supply-chain forces shaping demand while helping clients identify both upside opportunities and execution risks.

4. U.S. Single-Use Medical Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal

4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry

4.3. Pricing Trend Analysis, 2025–2035
4.3.1. Commodity Single-Use Device Pricing
4.3.2. Safety-Engineered Device Pricing
4.3.3. Specialty Procedural Device Pricing
4.3.4. Hospital Contract Pricing Dynamics
4.4. Value Chain & Supply Chain Analysis
4.4.1. Medical-Grade Raw Materials
4.4.2. Component Manufacturing
4.4.3. Device Assembly and Automation
4.4.4. Sterilization
4.4.5. Packaging and Labeling
4.4.6. Distribution and Logistics
4.4.7. Healthcare Provider Utilization
4.4.8. Disposal and Reprocessing Ecosystem
4.5. U.S. Manufacturing Footprint Analysis
4.6. Medical Device Sterilization Landscape
4.7. Raw Material and Polymer Dependency Analysis
4.8. Application & Innovation Landscape
4.9. FDA Regulatory Framework Analysis
4.9.1. Single-Use Device Classification
4.9.2. FDA 510(k) and Premarket Requirements
4.9.3. Quality Management System Regulation
4.9.4. Medical Device Reporting and Recall Requirements
4.9.5. Regulatory Framework for Reprocessed Single-Use Devices
4.10. CMS Reimbursement and Coverage Landscape
4.11. Import/Export Restrictions & Tariff Impact
4.12. Government Initiatives and Domestic Manufacturing Policies
4.13. Impact of Escalating Geopolitical Tensions
4.14. Hospital Value Analysis Committee Decision Framework
4.15. Sustainability and Medical Waste Management Landscape
4.16. Ethylene Oxide Sterilization and Regulatory Impact
4.17. Supply-Chain Resilience and Dual-Sourcing Analysis

What this section provides: This section gives clients a comprehensive understanding of the external market environment, regulation, reimbursement, manufacturing, sterilization, pricing, sustainability, supply-chain exposure, and hospital purchasing conditions affecting the U.S. single-use medical devices industry.

5. U.S. Single-Use Medical Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)

5.2. Infusion, Injection and Vascular Access Devices
5.2.1. Syringes
5.2.1.1. Conventional Syringes
5.2.1.2. Safety Syringes
5.2.1.3. Prefilled Flush Syringes
5.2.2. Hypodermic Needles
5.2.3. Safety Needles
5.2.4. Peripheral IV Catheters
5.2.5. Midline Catheters
5.2.6. Administration Sets
5.2.7. Extension Sets
5.2.8. Needleless Connectors
5.2.9. Closed-System Transfer Devices
5.2.10. Other Vascular Access Disposables

5.3. Surgical and Procedure-Specific Disposable Devices
5.3.1. Single-Use Surgical Instruments
5.3.2. Trocars and Access Devices
5.3.3. Surgical Stapling Consumables
5.3.4. Suction and Irrigation Devices
5.3.5. Drainage Devices
5.3.6. Electrosurgical Consumables
5.3.7. Minimally Invasive Surgical Accessories
5.3.8. Specialty Interventional Catheters
5.3.9. Custom Procedure Trays and Surgical Kits
5.3.10. Other Procedure-Specific Disposable Devices

5.4. Diagnostic and Specimen-Collection Devices
5.4.1. Blood Collection Tubes
5.4.2. Blood Collection Needles
5.4.3. Lancets
5.4.4. Swabs
5.4.5. Specimen Containers
5.4.6. Sample Transfer Devices
5.4.7. Point-of-Care Testing Consumables
5.4.8. Disposable Diagnostic Cartridges
5.4.9. Other Diagnostic Disposables

5.5. Wound Care, Ostomy and Drainage Products
5.5.1. Traditional Wound Dressings
5.5.2. Advanced Wound Dressings
5.5.3. Negative Pressure Wound Therapy Disposables
5.5.4. Surgical Wound Management Products
5.5.5. Ostomy Products and Accessories
5.5.6. Drainage Products
5.5.7. Skin Protection Products
5.5.8. Other Wound and Ostomy Consumables

5.6. Infection-Prevention and Sterile Barrier Devices
5.6.1. Sterile Drapes
5.6.2. Procedure Covers and Protective Sheaths
5.6.3. Regulated Medical Masks and Protective Devices
5.6.4. Closed-System Infection-Prevention Devices
5.6.5. Sterile Barrier Products
5.6.6. Other Infection-Prevention Devices

5.7. Respiratory, Anesthesia and Monitoring Disposables
5.7.1. Breathing Circuits
5.7.2. Oxygen Masks and Cannulas
5.7.3. Airway Management Consumables
5.7.4. Nebulizer Accessories
5.7.5. Respiratory Filters
5.7.6. Suction Accessories
5.7.7. Disposable ECG Electrodes
5.7.8. Disposable Pulse Oximetry Sensors
5.7.9. Disposable Temperature Probes
5.7.10. Other Patient Monitoring Disposables

What this section provides: This section identifies the disposable device categories generating the largest U.S. revenue pools and highlights product areas expected to achieve the strongest value growth, technology premiumization, and recurring consumption through 2035.

6. U.S. Single-Use Medical Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)

6.2. Medication Delivery and Infusion Therapy
6.2.1. Acute-Care Medication Administration
6.2.2. Oncology and Specialty Infusion
6.2.3. Home Infusion Therapy
6.2.4. Emergency Medication Administration
6.2.5. Vaccination and Injection Procedures

6.3. Surgery and Interventional Procedures
6.3.1. General Surgery
6.3.2. Cardiovascular Procedures
6.3.3. Orthopedic Procedures
6.3.4. Gastrointestinal Procedures
6.3.5. Urology Procedures
6.3.6. Gynecology Procedures
6.3.7. Neurovascular Procedures
6.3.8. Ophthalmic Procedures
6.3.9. Other Minimally Invasive Procedures

6.4. Diagnostics and Specimen Management
6.4.1. Clinical Laboratory Testing
6.4.2. Blood Collection and Processing
6.4.3. Molecular and Infectious Disease Testing
6.4.4. Point-of-Care Diagnostics
6.4.5. Preventive and Chronic Disease Testing

6.5. Wound and Chronic Disease Management
6.5.1. Diabetic Wound Care
6.5.2. Pressure Injury Management
6.5.3. Surgical Wound Management
6.5.4. Ostomy Care
6.5.5. Diabetes Management
6.5.6. Urinary and Continence Management
6.5.7. Long-Term Home Care

6.6. Infection Prevention, Respiratory and Critical Care
6.6.1. Infection Prevention
6.6.2. Critical Care
6.6.3. Respiratory Therapy
6.6.4. Anesthesia
6.6.5. Emergency and Trauma Care
6.6.6. Patient Monitoring

What this section provides: This section explains demand by clinical use case and identifies applications where procedure growth, recurring utilization, infection-control requirements, chronic disease management, and care-setting migration are creating the strongest commercial opportunities.

7. U.S. Single-Use Medical Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)

7.2. Hospitals and Integrated Health Systems
7.2.1. Academic Medical Centers
7.2.2. Community Hospitals
7.2.3. Specialty Hospitals
7.2.4. Critical Access Hospitals
7.2.5. Integrated Delivery Networks

7.3. Ambulatory Surgery Centers and Outpatient Facilities
7.3.1. Multispecialty ASCs
7.3.2. Specialty ASCs
7.3.3. Hospital Outpatient Departments
7.3.4. Office-Based Procedure Facilities

7.4. Physician Offices, Diagnostic Laboratories and Specialty Clinics
7.4.1. Physician Practices
7.4.2. Diagnostic Laboratories
7.4.3. Infusion Centers
7.4.4. Dialysis Centers
7.4.5. Wound Care Clinics
7.4.6. Specialty Treatment Centers

7.5. Home Healthcare and Long-Term Care
7.5.1. Home Healthcare Providers
7.5.2. Skilled Nursing Facilities
7.5.3. Long-Term Care Facilities
7.5.4. Direct-to-Patient Supply Programs

7.6. Emergency Medical Services and Other Care Settings
7.6.1. Emergency Medical Services
7.6.2. Urgent Care Centers
7.6.3. Public Health Programs
7.6.4. Federal Healthcare Facilities
7.6.5. Military Healthcare Facilities
7.6.6. Blood and Plasma Centers

What this section provides: This section explains which U.S. healthcare settings account for the largest disposable-device purchasing volumes and identifies customer groups expected to gain share as procedures and chronic care increasingly migrate outside traditional inpatient hospitals.

8. U.S. Single-Use Medical Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)

8.2. Conventional Sterile Single-Use Devices
8.2.1. Standard Injection and Infusion Devices
8.2.2. Conventional Catheters and Tubing
8.2.3. Standard Diagnostic Consumables
8.2.4. Traditional Wound and Respiratory Consumables

8.3. Safety-Engineered Devices
8.3.1. Retractable Needles
8.3.2. Passive Safety Syringes
8.3.3. Safety Blood Collection Devices
8.3.4. Blood-Control IV Catheters
8.3.5. Needleless Connectors
8.3.6. Sharps Protection Technologies

8.4. Closed-System, Prefilled and Procedure-Ready Devices
8.4.1. Prefilled Flush Syringes
8.4.2. Closed-System Transfer Devices
8.4.3. Preconnected Fluid Pathways
8.4.4. Custom Procedure Trays
8.4.5. Preassembled Surgical Kits
8.4.6. Procedure-Ready Delivery Systems

8.5. Advanced Single-Use Interventional Devices
8.5.1. Specialty Interventional Catheters
8.5.2. Thrombectomy Devices
8.5.3. Ablation Disposables
8.5.4. Minimally Invasive Surgical Instruments
8.5.5. Specialty Access and Delivery Systems

8.6. Disposable Sensors and Digitally Enabled Devices
8.6.1. Disposable ECG Sensors
8.6.2. Pulse Oximetry Sensors
8.6.3. Temperature Sensors
8.6.4. Pressure Monitoring Sensors
8.6.5. Wearable Diagnostic Patches
8.6.6. RFID-Enabled Single-Use Devices
8.6.7. Connected Single-Patient Monitoring Devices

What this section provides: This section evaluates how safety engineering, closed-system design, procedural integration, advanced interventional technology, and disposable digital sensing are shifting the market from commodity consumables toward higher-value medical device platforms.

9. U.S. Single-Use Medical Devices Market: Procurement, Supply Chain & Commercial Channel Analysis

9.1. Overview
9.2. Direct Hospital and Health System Procurement
9.3. Integrated Delivery Network Enterprise Contracts
9.4. Group Purchasing Organization Influence
9.5. National Medical-Surgical Distributor Channel
9.6. Regional and Specialty Distributor Channel
9.7. Ambulatory and Physician Office Procurement
9.8. Direct-to-Patient and Home Healthcare Distribution
9.9. E-Commerce and Digital Medical Supply Ordering
9.10. Federal and Government Procurement
9.11. Vendor Standardization and SKU Rationalization
9.12. Sole-Source vs. Dual-Source Contracting
9.13. Hospital Value Analysis Committee Requirements
9.14. Inventory and Safety Stock Strategies
9.15. Domestic Manufacturing Preference Analysis
9.16. Supplier Business Continuity Assessment
9.17. Contract Pricing and Rebate Structures
9.18. Procurement Decision-Making Criteria, 2025–2035

What this section provides: This section explains how single-use medical devices reach U.S. healthcare customers and how GPO leverage, IDN standardization, distribution networks, inventory security, contracting structures, and supply assurance influence manufacturer access and pricing power.

10. U.S. Single-Use Medical Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Hospital and Healthcare Infrastructure Analysis
10.1.4. Regional Procedure Volume and Device Utilization Analysis
10.1.5. Regional Chronic Disease and Demographic Demand Analysis
10.1.6. Regional Procurement and Distribution Dynamics
10.1.7. Regional Manufacturing and Supply-Chain Footprint
10.1.8. Regional Growth Opportunity Index

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Single-Use Medical Device Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Procurement, Supply Chain and Distribution Dynamics

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Procurement & Supply Chain Dynamics

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Procurement & Supply Chain Dynamics

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Procurement & Supply Chain Dynamics

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Procurement & Supply Chain Dynamics

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Procurement & Supply Chain Dynamics

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Procurement & Supply Chain Dynamics

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Procurement & Supply Chain Dynamics

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Procurement & Supply Chain Dynamics

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Procurement & Supply Chain Dynamics

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Procurement & Supply Chain Dynamics

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Procurement & Supply Chain Dynamics

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Procurement & Supply Chain Dynamics

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Procurement & Supply Chain Dynamics

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Single-Use Medical Device Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Procurement, Supply Chain and Distribution Dynamics

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Procurement & Supply Chain Dynamics

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Procurement & Supply Chain Dynamics

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Procurement & Supply Chain Dynamics

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Procurement & Supply Chain Dynamics

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Procurement & Supply Chain Dynamics

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Procurement & Supply Chain Dynamics

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Procurement & Supply Chain Dynamics

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Procurement & Supply Chain Dynamics

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Procurement & Supply Chain Dynamics

10.3.18. Delaware

10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Procurement & Supply Chain Dynamics

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Single-Use Medical Device Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Procurement, Supply Chain and Distribution Dynamics

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Procurement & Supply Chain Dynamics

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Procurement & Supply Chain Dynamics

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Procurement & Supply Chain Dynamics

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Procurement & Supply Chain Dynamics

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Procurement & Supply Chain Dynamics

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Procurement & Supply Chain Dynamics

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Procurement & Supply Chain Dynamics

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Procurement & Supply Chain Dynamics

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Procurement & Supply Chain Dynamics

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Procurement & Supply Chain Dynamics

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Procurement & Supply Chain Dynamics

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Procurement & Supply Chain Dynamics

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Procurement & Supply Chain Dynamics

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Procurement & Supply Chain Dynamics

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Procurement & Supply Chain Dynamics

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Single-Use Medical Device Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Procurement, Supply Chain and Distribution Dynamics

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Procurement & Supply Chain Dynamics

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Procurement & Supply Chain Dynamics

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Procurement & Supply Chain Dynamics

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Procurement & Supply Chain Dynamics

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Procurement & Supply Chain Dynamics

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Procurement & Supply Chain Dynamics

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Procurement & Supply Chain Dynamics

10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Procurement & Supply Chain Dynamics

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Procurement & Supply Chain Dynamics

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Procurement & Supply Chain Dynamics

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Procurement & Supply Chain Dynamics

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Procurement & Supply Chain Dynamics

What this section provides: This section delivers detailed four-region and 50-state analysis, helping clients identify priority U.S. geographies, high-consumption hospital markets, demographic demand centers, outpatient growth hubs, manufacturing clusters, distribution challenges, and state-level commercial opportunities.

11. U.S. Single-Use Medical Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Intensity Analysis
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging/Specialist Players
11.4. Competitive Benchmarking by Product Portfolio
11.5. Competitive Benchmarking by U.S. Manufacturing Footprint
11.6. Competitive Benchmarking by Hospital Contracting Strength
11.7. Competitive Benchmarking by Supply-Chain Resilience
11.8. Mergers, Acquisitions and Strategic Partnerships, 2021–2026
11.9. Recent Product, Manufacturing and Capacity Developments

11.10. Company Profiles

11.10.1. Becton, Dickinson and Company (BD)
11.10.2. Cardinal Health
11.10.3. Medline Industries
11.10.4. Baxter International
11.10.5. B. Braun Medical
11.10.6. Johnson & Johnson MedTech
11.10.7. Medtronic
11.10.8. Stryker
11.10.9. Boston Scientific Corporation
11.10.10. Abbott
11.10.11. Teleflex Incorporated
11.10.12. ICU Medical
11.10.13. Terumo Medical Corporation
11.10.14. Merit Medical Systems
11.10.15. Cook Medical
11.10.16. AngioDynamics
11.10.17. Smith+Nephew
11.10.18. Mölnlycke Health Care
11.10.19. Convatec Group
11.10.20. Coloplast
11.10.21. Solventum
11.10.22. Integra LifeSciences
11.10.23. Nipro Medical Corporation
11.10.24. Fresenius Kabi
11.10.25. Owens & Minor

11.11. Company Profile Parameters
11.11.1. Company Overview
11.11.2. Single-Use Medical Device Portfolio
11.11.3. Key U.S. Product Categories
11.11.4. U.S. Market Strategy
11.11.5. Manufacturing and Distribution Footprint
11.11.6. Financial and Competitive Positioning
11.11.7. FDA and Regulatory Updates
11.11.8. Product Innovation Pipeline
11.11.9. Partnerships, M&A and Capacity Investments
11.11.10. Recent Developments

What this section provides: This section gives clients competitor benchmarking, estimated market-share visibility, product portfolio positioning, manufacturing strength, hospital-channel exposure, innovation direction, supply-chain capabilities, and strategic intelligence on 25 major companies operating in the U.S. single-use medical devices market.

12. U.S. Single-Use Medical Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic/Base Scenario
12.1.3. Pessimistic Scenario

12.2. Disruptive Technologies Impact
12.2.1. Safety-Engineered Injection Systems
12.2.2. Smart and Integrated Vascular Access Devices
12.2.3. Closed-System and Prefilled Medical Devices
12.2.4. Single-Use Interventional Technologies
12.2.5. Disposable Biosensors and Wearable Monitoring
12.2.6. RFID and Digital Traceability
12.2.7. Automated High-Volume Manufacturing
12.2.8. Sustainable Medical-Grade Materials

12.3. Emerging Business Trends
12.3.1. Domestic Manufacturing Expansion
12.3.2. Supplier Consolidation and Portfolio Bundling
12.3.3. Dual-Sourcing and Supply Assurance Contracting
12.3.4. Procedure-Based Product Standardization
12.3.5. Shift Toward Home-Based Medical Supply Consumption
12.3.6. Sustainability-Driven Procurement
12.3.7. Growth of Reprocessing and Circular Device Models
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. High-Growth Product Opportunity Matrix
12.7. High-Growth State Opportunity Matrix
12.8. Technology Adoption Roadmap, 2026–2035
12.9. Expected Competitive Landscape Evolution
12.10. Market White-Space Analysis

What this section provides: This section prepares clients for future technology shifts, supply-chain restructuring, sustainability pressures, care-setting migration, competitive consolidation, investment opportunities, and potential market adoption scenarios through 2035.

13. U.S. Single-Use Medical Devices Market: Strategic Recommendations

13.1. Recommendations for Single-Use Device Manufacturers
13.1.1. Product Portfolio Prioritization
13.1.2. Premiumization Strategy
13.1.3. U.S. Manufacturing and Supply Resilience
13.1.4. Hospital Value-Evidence Development
13.1.5. Sustainability Strategy

13.2. Recommendations for Hospitals and Health Systems
13.2.1. Standardization and SKU Rationalization
13.2.2. Clinical Value Analysis
13.2.3. Dual-Sourcing Strategy
13.2.4. Original vs. Reprocessed Device Evaluation
13.2.5. Inventory Resilience

13.3. Recommendations for Investors and Private Equity Firms
13.3.1. High-Growth Product Categories
13.3.2. Specialty Disposable Device Platforms
13.3.3. Manufacturing and Contract Production Opportunities
13.3.4. Home Healthcare Distribution Opportunities
13.3.5. M&A White-Space Opportunities

13.4. Recommendations for Distributors and Channel Partners
13.4.1. Portfolio Expansion
13.4.2. Inventory Optimization
13.4.3. Direct-to-Patient Expansion
13.4.4. Regional Distribution Strategy
13.4.5. Digital Procurement Infrastructure

13.5. Recommendations for New Entrants and Startups
13.5.1. Market Entry Barriers
13.5.2. Regulatory Strategy
13.5.3. Clinical Differentiation
13.5.4. Contract Manufacturing Strategy
13.5.5. Hospital Pilot and KOL Strategy

13.6. Go-to-Market Strategy Considerations
13.7. Pricing and Contracting Strategy
13.8. Product Positioning and Portfolio Expansion Guidance
13.9. State-Level Commercial Prioritization
13.10. Partnership and Acquisition Strategy
13.11. Long-Term Competitive Differentiation Framework

What this section provides: This section converts market intelligence into actionable recommendations for manufacturers, providers, distributors, investors, startups, and other stakeholders seeking to improve market entry, portfolio positioning, contracting, channel expansion, investment allocation, and competitive differentiation.

14. U.S. Single-Use Medical Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Market Definition Limitation
14.4. Forecasting Limitation
14.5. State-Level Estimate Limitation
14.6. Competitive Share Estimate Limitation
14.7. Legal Disclaimer
14.8. Third-Party Data Disclaimer
14.9. Regulatory and Reimbursement Disclaimer
14.10. Forward-Looking Statements Disclaimer

What this section provides: This section clarifies the report’s scope boundaries, methodological limitations, state-level estimation constraints, competitive-share assumptions, forecasting limitations, regulatory considerations, legal boundaries, and permitted use of market intelligence.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Single-Use Medical Devices Market: Market Definition and Scope
TABLE 3: U.S. Single-Use Medical Devices Market: Devices Included in Market Scope
TABLE 4: U.S. Single-Use Medical Devices Market: Market Exclusions and Boundary Definition
TABLE 5: U.S. Single-Use Medical Devices Market: Original Single-Use vs. Reprocessed Single-Use Device Framework
TABLE 6: U.S. Single-Use Medical Devices Market: Research Methodology Framework
TABLE 7: U.S. Single-Use Medical Devices Market: Primary Data Collection Framework
TABLE 8: U.S. Single-Use Medical Devices Market: Secondary Data Sourcing Framework
TABLE 9: U.S. Single-Use Medical Devices Market: Analytical and Forecasting Model
TABLE 10: U.S. Single-Use Medical Devices Market: Data Triangulation and Validation Framework
TABLE 11: U.S. Single-Use Medical Devices Market: Key Assumptions
TABLE 12: U.S. Single-Use Medical Devices Market: Market Ecosystem Overview
TABLE 13: U.S. Single-Use Medical Devices Market: Stakeholder Analysis
TABLE 14: U.S. Single-Use Medical Devices Market: Manufacturer and Supplier Ecosystem
TABLE 15: U.S. Single-Use Medical Devices Market: Hospital, GPO and Distributor Ecosystem
TABLE 16: U.S. Single-Use Medical Devices Market: Executive Summary Snapshot, 2025
TABLE 17: U.S. Single-Use Medical Devices Market: Analyst Viewpoint Summary
TABLE 18: U.S. Single-Use Medical Devices Market: Market Attractiveness Index
TABLE 19: U.S. Single-Use Medical Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 20: U.S. Single-Use Medical Devices Market: Base Year Market Size, 2025 (US$ Billion)
TABLE 21: U.S. Single-Use Medical Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 22: U.S. Single-Use Medical Devices Market: Year-Wise Market Size, 2021–2035 (US$ Billion)
TABLE 23: U.S. Single-Use Medical Devices Market: CAGR Analysis, 2026–2035 (%)
TABLE 24: U.S. Single-Use Medical Devices Market: High-Growth Opportunity Areas, 2026–2035
TABLE 25: U.S. Single-Use Medical Devices Market: Key Strategic Takeaways
TABLE 26: U.S. Single-Use Medical Devices Market: Drivers; Impact Analysis
TABLE 27: U.S. Single-Use Medical Devices Market: High Recurring Healthcare Consumption Impact
TABLE 28: U.S. Single-Use Medical Devices Market: Infection Prevention Demand Impact
TABLE 29: U.S. Single-Use Medical Devices Market: Ambulatory and Outpatient Procedure Expansion Impact
TABLE 30: U.S. Single-Use Medical Devices Market: Aging Population and Chronic Disease Impact
TABLE 31: U.S. Single-Use Medical Devices Market: Safety-Engineered Device Adoption Impact
TABLE 32: U.S. Single-Use Medical Devices Market: Home Healthcare Expansion Impact
TABLE 33: U.S. Single-Use Medical Devices Market: Supply-Chain Resilience Impact
TABLE 34: U.S. Single-Use Medical Devices Market: Restraints; Impact Analysis
TABLE 35: U.S. Single-Use Medical Devices Market: Commodity Pricing Pressure Analysis
TABLE 36: U.S. Single-Use Medical Devices Market: GPO and IDN Purchasing Pressure Analysis
TABLE 37: U.S. Single-Use Medical Devices Market: Medical Plastic Waste and Sustainability Challenge
TABLE 38: U.S. Single-Use Medical Devices Market: Raw Material and Sterilization Cost Risk
TABLE 39: U.S. Single-Use Medical Devices Market: Product Recall and Quality Risk
TABLE 40: U.S. Single-Use Medical Devices Market: Reprocessing Competition Analysis
TABLE 41: U.S. Single-Use Medical Devices Market: Opportunities; Impact Analysis
TABLE 42: U.S. Single-Use Medical Devices Market: Safety-Engineered Injection Device Opportunity
TABLE 43: U.S. Single-Use Medical Devices Market: Integrated Vascular Access Opportunity
TABLE 44: U.S. Single-Use Medical Devices Market: Procedure-Ready Kit Opportunity
TABLE 45: U.S. Single-Use Medical Devices Market: Advanced Interventional Device Opportunity
TABLE 46: U.S. Single-Use Medical Devices Market: Disposable Sensor Opportunity
TABLE 47: U.S. Single-Use Medical Devices Market: Sustainable Device Opportunity
TABLE 48: U.S. Single-Use Medical Devices Market: Domestic Manufacturing Opportunity
TABLE 49: U.S. Single-Use Medical Devices Market: Challenges; Impact Analysis
TABLE 50: U.S. Single-Use Medical Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 51: U.S. Single-Use Medical Devices Market: Clinical Workflow Economics Matrix
TABLE 52: U.S. Single-Use Medical Devices Market: Cost-Per-Procedure Economics Matrix
TABLE 53: U.S. Single-Use Medical Devices Market: Hospital Procurement Behavior Matrix
TABLE 54: U.S. Single-Use Medical Devices Market: Single-Use vs. Reusable Device Economics
TABLE 55: U.S. Single-Use Medical Devices Market: Original vs. Reprocessed Single-Use Device Economics
TABLE 56: U.S. Single-Use Medical Devices Market: Supply Shortage and Business Continuity Analysis
TABLE 57: U.S. Single-Use Medical Devices Market: PESTEL Analysis
TABLE 58: U.S. Single-Use Medical Devices Market: Political Factors
TABLE 59: U.S. Single-Use Medical Devices Market: Economic Factors
TABLE 60: U.S. Single-Use Medical Devices Market: Social Factors
TABLE 61: U.S. Single-Use Medical Devices Market: Technological Factors
TABLE 62: U.S. Single-Use Medical Devices Market: Environmental Factors
TABLE 63: U.S. Single-Use Medical Devices Market: Legal Factors
TABLE 64: U.S. Single-Use Medical Devices Market: Porter’s Five Forces Analysis
TABLE 65: U.S. Single-Use Medical Devices Market: Threat of New Entrants
TABLE 66: U.S. Single-Use Medical Devices Market: Bargaining Power of Buyers
TABLE 67: U.S. Single-Use Medical Devices Market: Bargaining Power of Suppliers
TABLE 68: U.S. Single-Use Medical Devices Market: Substitution Risk
TABLE 69: U.S. Single-Use Medical Devices Market: Competitive Rivalry
TABLE 70: U.S. Single-Use Medical Devices Market: Pricing Trend Analysis, 2025–2035
TABLE 71: U.S. Single-Use Medical Devices Market: Commodity Product Pricing Trends
TABLE 72: U.S. Single-Use Medical Devices Market: Safety-Engineered Product Pricing Trends
TABLE 73: U.S. Single-Use Medical Devices Market: Specialty Procedural Device Pricing Trends
TABLE 74: U.S. Single-Use Medical Devices Market: Value Chain Analysis
TABLE 75: U.S. Single-Use Medical Devices Market: Supply Chain Analysis
TABLE 76: U.S. Single-Use Medical Devices Market: Medical-Grade Raw Material Dependency
TABLE 77: U.S. Single-Use Medical Devices Market: U.S. Manufacturing Footprint Analysis
TABLE 78: U.S. Single-Use Medical Devices Market: Medical Device Sterilization Landscape
TABLE 79: U.S. Single-Use Medical Devices Market: FDA Regulatory Framework Analysis
TABLE 80: U.S. Single-Use Medical Devices Market: Quality Management System Regulation Analysis
TABLE 81: U.S. Single-Use Medical Devices Market: Reprocessed Single-Use Device Regulatory Framework
TABLE 82: U.S. Single-Use Medical Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 83: U.S. Single-Use Medical Devices Market: Import, Export and Tariff Impact
TABLE 84: U.S. Single-Use Medical Devices Market: Government and Domestic Manufacturing Initiatives
TABLE 85: U.S. Single-Use Medical Devices Market: Geopolitical Supply-Chain Impact
TABLE 86: U.S. Single-Use Medical Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 87: U.S. Single-Use Medical Devices Market: Sustainability and Medical Waste Management Landscape
TABLE 88: U.S. Single-Use Medical Devices Market: Ethylene Oxide Sterilization Impact
TABLE 89: U.S. Single-Use Medical Devices Market: Product Category Snapshot, 2025
TABLE 90: Segment Dashboard; Definition and Scope, by Product Category
TABLE 91: U.S. Single-Use Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 92: U.S. Single-Use Medical Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 93: Infusion, Injection and Vascular Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 94: Syringes Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 95: Hypodermic and Safety Needles Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 96: Peripheral IV Catheters Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: Midline Catheters Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: Administration and Extension Sets Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 99: Needleless Connectors and Closed-System Transfer Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Surgical and Procedure-Specific Disposable Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Single-Use Surgical Instruments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Trocars and Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Surgical Stapling Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: Suction, Irrigation and Drainage Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Electrosurgical Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: Specialty Interventional Catheters Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Custom Procedure Trays and Surgical Kits Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Diagnostic and Specimen-Collection Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Blood Collection Tubes Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: Blood Collection Needles and Lancets Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: Swabs and Specimen Containers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: Point-of-Care Testing Consumables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 113: Disposable Diagnostic Cartridges Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 114: Wound Care, Ostomy and Drainage Products Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 115: Traditional and Advanced Wound Dressings Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 116: Negative Pressure Wound Therapy Disposables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: Ostomy Products and Accessories Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: Infection-Prevention and Sterile Barrier Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 119: Sterile Drapes and Barrier Products Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 120: Procedure Covers, Sheaths and Closed-System Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 121: Respiratory, Anesthesia and Monitoring Disposables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 122: Breathing Circuits, Masks and Cannulas Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Airway Management and Respiratory Filters Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Disposable ECG, Pulse Oximetry and Temperature Sensors Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: U.S. Single-Use Medical Devices Market: Application Snapshot, 2025
TABLE 126: Segment Dashboard; Definition and Scope, by Application
TABLE 127: U.S. Single-Use Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 128: U.S. Single-Use Medical Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 129: Medication Delivery and Infusion Therapy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: Acute-Care Medication Administration Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Oncology and Specialty Infusion Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: Home Infusion Therapy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 133: Surgery and Interventional Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 134: General Surgery Application Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 135: Cardiovascular Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: Orthopedic Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: Gastrointestinal Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Urology and Gynecology Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: Neurovascular and Other Minimally Invasive Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Diagnostics and Specimen Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: Clinical Laboratory Testing Application Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Point-of-Care and Molecular Diagnostics Application Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Wound and Chronic Disease Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Diabetic and Surgical Wound Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: Ostomy, Diabetes and Urinary Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Infection Prevention, Respiratory and Critical Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: Critical Care and Respiratory Therapy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Anesthesia, Emergency and Patient Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: U.S. Single-Use Medical Devices Market: End User Snapshot, 2025
TABLE 150: Segment Dashboard; Definition and Scope, by End User
TABLE 151: U.S. Single-Use Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 152: U.S. Single-Use Medical Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 153: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: Academic Medical Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: Community and Specialty Hospitals Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 156: Integrated Delivery Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 157: Ambulatory Surgery Centers and Outpatient Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 158: Multispecialty and Specialty ASCs Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 159: Hospital Outpatient Departments Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 160: Physician Offices, Diagnostic Laboratories and Specialty Clinics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 161: Diagnostic Laboratories Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 162: Infusion, Dialysis and Wound Care Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 163: Home Healthcare and Long-Term Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: Skilled Nursing and Long-Term Care Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 165: Direct-to-Patient Supply Programs Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 166: Emergency Medical Services and Other Care Settings Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 167: U.S. Single-Use Medical Devices Market: Technology Type Snapshot, 2025
TABLE 168: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 169: U.S. Single-Use Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 170: U.S. Single-Use Medical Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 171: Conventional Sterile Single-Use Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 172: Safety-Engineered Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 173: Retractable Needle and Passive Safety Syringe Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 174: Safety Blood Collection and Blood-Control Catheter Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 175: Closed-System, Prefilled and Procedure-Ready Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 176: Prefilled Flush Syringes and Closed-System Transfer Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 177: Custom Procedure Trays and Preassembled Kits Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 178: Advanced Single-Use Interventional Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 179: Specialty Catheter and Thrombectomy Device Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 180: Ablation and Minimally Invasive Surgical Disposable Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 181: Disposable Sensors and Digitally Enabled Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 182: Disposable Biosensor and Wearable Patch Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 183: RFID-Enabled and Connected Single-Patient Device Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 184: U.S. Single-Use Medical Devices Market: Procurement and Commercial Channel Snapshot, 2025
TABLE 185: U.S. Single-Use Medical Devices Market: Direct Hospital Procurement Analysis
TABLE 186: U.S. Single-Use Medical Devices Market: Integrated Delivery Network Contracting Analysis
TABLE 187: U.S. Single-Use Medical Devices Market: Group Purchasing Organization Analysis
TABLE 188: U.S. Single-Use Medical Devices Market: National Distributor Channel Analysis
TABLE 189: U.S. Single-Use Medical Devices Market: Regional and Specialty Distributor Analysis
TABLE 190: U.S. Single-Use Medical Devices Market: Ambulatory Procurement Analysis
TABLE 191: U.S. Single-Use Medical Devices Market: Direct-to-Patient Distribution Analysis
TABLE 192: U.S. Single-Use Medical Devices Market: E-Commerce Medical Supply Channel Analysis
TABLE 193: U.S. Single-Use Medical Devices Market: Federal and Government Procurement Analysis
TABLE 194: U.S. Single-Use Medical Devices Market: Vendor Standardization and SKU Rationalization Matrix
TABLE 195: U.S. Single-Use Medical Devices Market: Sole-Source vs. Dual-Source Contracting Analysis
TABLE 196: U.S. Single-Use Medical Devices Market: Supplier Business Continuity Assessment
TABLE 197: U.S. Single-Use Medical Devices Market: Regional Snapshot, 2025
TABLE 198: Segment Dashboard; Definition and Scope, by Region
TABLE 199: U.S. Single-Use Medical Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 200: U.S. Single-Use Medical Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 201: West Region U.S. Single-Use Medical Devices Market: Regional Overview and Trends
TABLE 202: West Region U.S. Single-Use Medical Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 203: West Region U.S. Single-Use Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 204: West Region U.S. Single-Use Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 205: West Region U.S. Single-Use Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 206: West Region U.S. Single-Use Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 207: West Region U.S. Single-Use Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 208: California Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 209: Washington Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 210: Arizona Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 211: Colorado Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 212: Oregon Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 213: Utah Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 214: Nevada Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 215: New Mexico Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 216: Idaho Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 217: Montana Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 218: Wyoming Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 219: Alaska Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 220: Hawaii Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 221: Northeast Region U.S. Single-Use Medical Devices Market: Regional Overview and Trends
TABLE 222: Northeast Region U.S. Single-Use Medical Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 223: Northeast Region U.S. Single-Use Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 224: Northeast Region U.S. Single-Use Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 225: Northeast Region U.S. Single-Use Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 226: Northeast Region U.S. Single-Use Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 227: Northeast Region U.S. Single-Use Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 228: New York Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 229: Massachusetts Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 230: New Jersey Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 231: Pennsylvania Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 232: Connecticut Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 233: Maine Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 234: Vermont Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 235: New Hampshire Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 236: Rhode Island Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 237: Delaware Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 238: South Region U.S. Single-Use Medical Devices Market: Regional Overview and Trends
TABLE 239: South Region U.S. Single-Use Medical Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 240: South Region U.S. Single-Use Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 241: South Region U.S. Single-Use Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 242: South Region U.S. Single-Use Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 243: South Region U.S. Single-Use Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 244: South Region U.S. Single-Use Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 245: Texas Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 246: Florida Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 247: Georgia Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 248: North Carolina Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 249: Tennessee Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 250: South Carolina Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 251: Alabama Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 252: Mississippi Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 253: Louisiana Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 254: Arkansas Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 255: Kentucky Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 256: Oklahoma Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 257: Virginia Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 258: Maryland Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 259: West Virginia Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 260: Midwest Region U.S. Single-Use Medical Devices Market: Regional Overview and Trends
TABLE 261: Midwest Region U.S. Single-Use Medical Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 262: Midwest Region U.S. Single-Use Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 263: Midwest Region U.S. Single-Use Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 264: Midwest Region U.S. Single-Use Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 265: Midwest Region U.S. Single-Use Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 266: Midwest Region U.S. Single-Use Medical Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 267: Illinois Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 268: Ohio Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 269: Michigan Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 270: Minnesota Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 271: Indiana Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 272: Wisconsin Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 273: Missouri Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 274: Iowa Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 275: Kansas Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 276: Nebraska Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 277: North Dakota Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 278: South Dakota Single-Use Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 279: U.S. Single-Use Medical Devices Market: State-Level Market Ranking, 2025
TABLE 280: U.S. Single-Use Medical Devices Market: State-Level Growth Opportunity, 2026–2035
TABLE 281: U.S. Single-Use Medical Devices Market: Competitive Landscape Snapshot, 2025
TABLE 282: U.S. Single-Use Medical Devices Market: Key Company Market Share Analysis, 2025
TABLE 283: U.S. Single-Use Medical Devices Market: Company Positioning Matrix
TABLE 284: U.S. Single-Use Medical Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 285: U.S. Single-Use Medical Devices Market: U.S. Manufacturing Footprint Benchmarking
TABLE 286: U.S. Single-Use Medical Devices Market: Supply-Chain Resilience Benchmarking
TABLE 287: U.S. Single-Use Medical Devices Market: Hospital Contracting Strength Benchmarking
TABLE 288: U.S. Single-Use Medical Devices Market: Strategic Developments, Partnerships, M&A and Capacity Investments
TABLE 289: Becton, Dickinson and Company (BD): Company Profile
TABLE 290: Cardinal Health: Company Profile
TABLE 291: Medline Industries: Company Profile
TABLE 292: Baxter International: Company Profile
TABLE 293: B. Braun Medical: Company Profile
TABLE 294: Johnson & Johnson MedTech: Company Profile
TABLE 295: Medtronic: Company Profile
TABLE 296: Stryker: Company Profile
TABLE 297: Boston Scientific Corporation: Company Profile
TABLE 298: Abbott: Company Profile
TABLE 299: Teleflex Incorporated: Company Profile
TABLE 300: ICU Medical: Company Profile
TABLE 301: Terumo Medical Corporation: Company Profile
TABLE 302: Merit Medical Systems: Company Profile
TABLE 303: Cook Medical: Company Profile
TABLE 304: AngioDynamics: Company Profile
TABLE 305: Smith+Nephew: Company Profile
TABLE 306: Mölnlycke Health Care: Company Profile
TABLE 307: Convatec Group: Company Profile
TABLE 308: Coloplast: Company Profile
TABLE 309: Solventum: Company Profile
TABLE 310: Integra LifeSciences: Company Profile
TABLE 311: Nipro Medical Corporation: Company Profile
TABLE 312: Fresenius Kabi: Company Profile
TABLE 313: Owens & Minor: Company Profile
TABLE 314: U.S. Single-Use Medical Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 315: U.S. Single-Use Medical Devices Market: Optimistic Scenario, 2026–2035
TABLE 316: U.S. Single-Use Medical Devices Market: Base Scenario, 2026–2035
TABLE 317: U.S. Single-Use Medical Devices Market: Pessimistic Scenario, 2026–2035
TABLE 318: U.S. Single-Use Medical Devices Market: Disruptive Technologies Impact Matrix
TABLE 319: U.S. Single-Use Medical Devices Market: Safety-Engineered Device Opportunity Matrix
TABLE 320: U.S. Single-Use Medical Devices Market: Smart Vascular Access Opportunity Matrix
TABLE 321: U.S. Single-Use Medical Devices Market: Closed-System and Prefilled Device Opportunity Matrix
TABLE 322: U.S. Single-Use Medical Devices Market: Disposable Biosensor Opportunity Matrix
TABLE 323: U.S. Single-Use Medical Devices Market: Sustainable Material Opportunity Matrix
TABLE 324: U.S. Single-Use Medical Devices Market: Emerging Business Trends
TABLE 325: U.S. Single-Use Medical Devices Market: Business Opportunities for Startups and Existing Players
TABLE 326: U.S. Single-Use Medical Devices Market: Investment Prioritization Matrix
TABLE 327: U.S. Single-Use Medical Devices Market: High-Growth Product Opportunity Matrix
TABLE 328: U.S. Single-Use Medical Devices Market: High-Growth State Opportunity Matrix
TABLE 329: U.S. Single-Use Medical Devices Market: Strategic Recommendations for Manufacturers
TABLE 330: U.S. Single-Use Medical Devices Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 331: U.S. Single-Use Medical Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 332: U.S. Single-Use Medical Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 333: U.S. Single-Use Medical Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 334: U.S. Single-Use Medical Devices Market: Go-to-Market Strategy Considerations
TABLE 335: U.S. Single-Use Medical Devices Market: Pricing and Contracting Strategy
TABLE 336: U.S. Single-Use Medical Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 337: U.S. Single-Use Medical Devices Market: State-Level Commercial Prioritization
TABLE 338: U.S. Single-Use Medical Devices Market: Partnership and Acquisition Strategy
TABLE 339: U.S. Single-Use Medical Devices Market: Scope Limitation
TABLE 340: U.S. Single-Use Medical Devices Market: Data Use Limitation
TABLE 341: U.S. Single-Use Medical Devices Market: Market Definition Limitation
TABLE 342: U.S. Single-Use Medical Devices Market: Forecasting Limitation
TABLE 343: U.S. Single-Use Medical Devices Market: State-Level Estimate Limitation
TABLE 344: U.S. Single-Use Medical Devices Market: Competitive Share Estimate Limitation
TABLE 345: U.S. Single-Use Medical Devices Market: Legal Disclaimer
TABLE 346: U.S. Single-Use Medical Devices Market: Third-Party Data Disclaimer
TABLE 347: U.S. Single-Use Medical Devices Market: Regulatory and Reimbursement Disclaimer
TABLE 348: U.S. Single-Use Medical Devices Market: Forward-Looking Statements Disclaimer

List of Figures

FIGURE 1: U.S. Single-Use Medical Devices Market Segmentation
FIGURE 2: U.S. Single-Use Medical Devices Market Definition and Scope Framework
FIGURE 3: Market Research Methodology
FIGURE 4: Bottom-Up and Top-Down Market Estimation Framework
FIGURE 5: U.S. Single-Use Medical Devices Market Ecosystem
FIGURE 6: U.S. Single-Use Medical Devices Stakeholder Ecosystem
FIGURE 7: U.S. Single-Use Medical Devices Value Chain Analysis
FIGURE 8: U.S. Single-Use Medical Devices Supply Chain Analysis
FIGURE 9: Market Attractiveness Analysis
FIGURE 10: U.S. Single-Use Medical Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 11: U.S. Single-Use Medical Devices Market Size, Base Year Analysis, 2025 (US$ Billion)
FIGURE 12: U.S. Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 13: U.S. Single-Use Medical Devices Market Year-Wise Growth Curve, 2021–2035
FIGURE 14: U.S. Single-Use Medical Devices Market CAGR Analysis, 2026–2035
FIGURE 15: U.S. Single-Use Medical Devices Market Dynamics
FIGURE 16: Market Drivers Impact Matrix
FIGURE 17: Market Restraints Impact Matrix
FIGURE 18: Market Opportunity Impact Matrix
FIGURE 19: Market Challenges Impact Matrix
FIGURE 20: Innovation & Patent Landscape, 2021–2025
FIGURE 21: Clinical Workflow Economics Framework
FIGURE 22: Cost-Per-Procedure Economics Framework
FIGURE 23: Single-Use vs. Reusable Medical Device Economics Framework
FIGURE 24: Original vs. Reprocessed Single-Use Device Economics Framework
FIGURE 25: Hospital Procurement Decision Framework
FIGURE 26: Supply Shortage and Business Continuity Risk Matrix
FIGURE 27: PESTEL Analysis
FIGURE 28: Porter’s Five Forces Analysis
FIGURE 29: U.S. Single-Use Medical Devices Pricing Trend Analysis, 2025–2035
FIGURE 30: U.S. Manufacturing Footprint Framework
FIGURE 31: Medical Device Sterilization Ecosystem
FIGURE 32: Medical-Grade Polymer and Raw Material Dependency Framework
FIGURE 33: FDA Regulatory Framework for Single-Use Medical Devices
FIGURE 34: Quality Management System Regulation Framework
FIGURE 35: Reprocessed Single-Use Device Regulatory Framework
FIGURE 36: CMS Reimbursement and Coverage Landscape
FIGURE 37: Import, Tariff and Geopolitical Exposure Framework
FIGURE 38: Hospital Value Analysis Committee Decision Framework
FIGURE 39: Medical Waste and Sustainability Framework
FIGURE 40: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 41: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Infusion, Injection and Vascular Access Devices Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 43: Syringes Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 44: Hypodermic and Safety Needles Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 45: Peripheral IV Catheters Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 46: Administration Sets and Needleless Connectors Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 47: Surgical and Procedure-Specific Disposable Devices Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 48: Single-Use Surgical Instruments Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 49: Surgical Stapling and Access Devices Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 50: Specialty Interventional Catheters Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 51: Custom Procedure Trays and Surgical Kits Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 52: Diagnostic and Specimen-Collection Devices Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 53: Blood Collection Products Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 54: Point-of-Care Diagnostic Consumables Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 55: Wound Care, Ostomy and Drainage Products Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 56: Advanced Wound Care Disposables Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 57: Infection-Prevention and Sterile Barrier Devices Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 58: Respiratory, Anesthesia and Monitoring Disposables Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 59: Disposable Monitoring Sensors Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 60: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 61: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Medication Delivery and Infusion Therapy Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 63: Acute-Care Medication Administration Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 64: Oncology and Home Infusion Therapy Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 65: Surgery and Interventional Procedures Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 66: General and Minimally Invasive Surgery Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 67: Cardiovascular and Interventional Procedure Disposable Device Demand Outlook, 2021–2035
FIGURE 68: Diagnostics and Specimen Management Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 69: Wound and Chronic Disease Management Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 70: Infection Prevention, Respiratory and Critical Care Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 71: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 72: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 74: Academic, Community and Specialty Hospital Demand Outlook, 2021–2035
FIGURE 75: Ambulatory Surgery Centers and Outpatient Facilities Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 76: Physician Offices, Diagnostic Laboratories and Specialty Clinics Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 77: Home Healthcare and Long-Term Care Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 78: Emergency Medical Services and Other Care Settings Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 79: U.S. Care-Setting Migration and Disposable Device Demand Framework
FIGURE 80: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 81: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Conventional Sterile Single-Use Devices Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 83: Safety-Engineered Devices Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 84: Safety Syringe and Sharps Protection Adoption Roadmap
FIGURE 85: Closed-System, Prefilled and Procedure-Ready Devices Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 86: Prefilled and Closed-System Device Adoption Roadmap
FIGURE 87: Advanced Single-Use Interventional Devices Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 88: Specialty Catheter and Thrombectomy Device Growth Roadmap
FIGURE 89: Disposable Sensors and Digitally Enabled Devices Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 90: Disposable Biosensor and Wearable Monitoring Adoption Roadmap
FIGURE 91: U.S. Single-Use Medical Device Procurement Ecosystem
FIGURE 92: Direct Hospital and IDN Procurement Structure
FIGURE 93: GPO and Distributor Channel Structure
FIGURE 94: Ambulatory and Direct-to-Patient Distribution Structure
FIGURE 95: Hospital Vendor Evaluation Framework
FIGURE 96: Vendor Standardization and SKU Rationalization Framework
FIGURE 97: Sole-Source vs. Dual-Source Contracting Framework
FIGURE 98: Supply Assurance and Business Continuity Framework
FIGURE 99: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 100: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: U.S. Single-Use Medical Devices Regional Growth Opportunity Map
FIGURE 102: West Region U.S. Single-Use Medical Devices Market Share and Leading Players, 2025
FIGURE 103: West Region Market Share Analysis by State, 2025
FIGURE 104: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: California Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 106: Washington Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 107: Arizona Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 108: Colorado Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 109: Oregon Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 110: Utah Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 111: Nevada Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 112: New Mexico Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 113: Idaho Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 114: Montana Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 115: Wyoming Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 116: Alaska Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 117: Hawaii Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 118: Northeast Region U.S. Single-Use Medical Devices Market Share and Leading Players, 2025
FIGURE 119: Northeast Region Market Share Analysis by State, 2025
FIGURE 120: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 121: New York Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 122: Massachusetts Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 123: New Jersey Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 124: Pennsylvania Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 125: Connecticut Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 126: Maine Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 127: Vermont Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 128: New Hampshire Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 129: Rhode Island Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 130: Delaware Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 131: South Region U.S. Single-Use Medical Devices Market Share and Leading Players, 2025
FIGURE 132: South Region Market Share Analysis by State, 2025
FIGURE 133: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 134: Texas Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 135: Florida Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 136: Georgia Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 137: North Carolina Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 138: Tennessee Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 139: South Carolina Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 140: Alabama Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 141: Mississippi Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 142: Louisiana Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 143: Arkansas Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 144: Kentucky Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 145: Oklahoma Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 146: Virginia Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 147: Maryland Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 148: West Virginia Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 149: Midwest Region U.S. Single-Use Medical Devices Market Share and Leading Players, 2025
FIGURE 150: Midwest Region Market Share Analysis by State, 2025
FIGURE 151: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 152: Illinois Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 153: Ohio Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 154: Michigan Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 155: Minnesota Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 156: Indiana Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 157: Wisconsin Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 158: Missouri Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 159: Iowa Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 160: Kansas Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 161: Nebraska Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 162: North Dakota Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 163: South Dakota Single-Use Medical Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 164: U.S. State-Level Single-Use Medical Devices Market Attractiveness Heat Map, 2025
FIGURE 165: Leading U.S. States by Single-Use Medical Devices Market Size, 2025
FIGURE 166: Fastest-Growing U.S. State Markets, 2026–2035
FIGURE 167: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 168: Company Positioning Matrix
FIGURE 169: Key Player Product Portfolio Benchmarking
FIGURE 170: Key Player U.S. Manufacturing Footprint Benchmarking
FIGURE 171: Key Player Supply-Chain Resilience Benchmarking
FIGURE 172: Hospital Contracting Strength Benchmarking
FIGURE 173: Strategic Developments, Partnerships, M&A and Capacity Investments
FIGURE 174: Becton, Dickinson and Company Competitive Positioning
FIGURE 175: Cardinal Health Competitive Positioning
FIGURE 176: Medline Industries Competitive Positioning
FIGURE 177: Baxter International Competitive Positioning
FIGURE 178: B. Braun Medical Competitive Positioning
FIGURE 179: Johnson & Johnson MedTech Competitive Positioning
FIGURE 180: Medtronic Competitive Positioning
FIGURE 181: Stryker Competitive Positioning
FIGURE 182: Boston Scientific Corporation Competitive Positioning
FIGURE 183: Abbott Competitive Positioning
FIGURE 184: Teleflex Incorporated Competitive Positioning
FIGURE 185: ICU Medical Competitive Positioning
FIGURE 186: Terumo Medical Corporation Competitive Positioning
FIGURE 187: Merit Medical Systems Competitive Positioning
FIGURE 188: Cook Medical Competitive Positioning
FIGURE 189: AngioDynamics Competitive Positioning
FIGURE 190: Smith+Nephew Competitive Positioning
FIGURE 191: Mölnlycke Health Care Competitive Positioning
FIGURE 192: Convatec Group Competitive Positioning
FIGURE 193: Coloplast Competitive Positioning
FIGURE 194: Solventum Competitive Positioning
FIGURE 195: Integra LifeSciences Competitive Positioning
FIGURE 196: Nipro Medical Corporation Competitive Positioning
FIGURE 197: Fresenius Kabi Competitive Positioning
FIGURE 198: Owens & Minor Competitive Positioning
FIGURE 199: U.S. Single-Use Medical Devices Innovation Roadmap
FIGURE 200: Future Market Scenario Analysis, 2026–2035
FIGURE 201: Optimistic, Base and Pessimistic Forecast Comparison, 2026–2035
FIGURE 202: Disruptive Technologies Impact Matrix
FIGURE 203: Safety-Engineered Medical Device Adoption Roadmap
FIGURE 204: Smart Vascular Access Technology Roadmap
FIGURE 205: Closed-System and Prefilled Medical Device Opportunity Map
FIGURE 206: Advanced Single-Use Interventional Device Opportunity Map
FIGURE 207: Disposable Biosensor and Connected Monitoring Growth Roadmap
FIGURE 208: Sustainable Materials and Lower-Waste Device Innovation Roadmap
FIGURE 209: Domestic Manufacturing Expansion Roadmap
FIGURE 210: Emerging Business Trends Matrix
FIGURE 211: Business Opportunity Matrix for Startups and Existing Players
FIGURE 212: Investment Prioritization Matrix
FIGURE 213: High-Growth Product Opportunity Matrix
FIGURE 214: High-Growth State Opportunity Matrix
FIGURE 215: U.S. Single-Use Medical Devices Technology Adoption Roadmap, 2026–2035
FIGURE 216: Future Competitive Landscape Evolution, 2026–2035
FIGURE 217: Strategic Growth Roadmap for U.S. Single-Use Medical Device Manufacturers
FIGURE 218: Strategic Procurement Roadmap for Hospitals and Health Systems
FIGURE 219: Investor and Private Equity Opportunity Framework
FIGURE 220: Distributor and Channel Expansion Framework
FIGURE 221: Market Entry Framework for New Entrants and Startups
FIGURE 222: Go-to-Market Strategy Framework
FIGURE 223: Pricing and Contracting Strategy Framework
FIGURE 224: Product Positioning and Portfolio Expansion Framework
FIGURE 225: U.S. State-Level Commercial Prioritization Framework
FIGURE 226: Partnership and Acquisition Strategy Framework
FIGURE 227: Long-Term Competitive Differentiation Framework
FIGURE 228: Report Scope Limitation Framework
FIGURE 229: Market Forecasting and State-Level Estimation Limitation Framework
FIGURE 230: Regulatory, Legal and Third-Party Data Disclaimer Framework